Jeffrey Jones to Risk Factors
This is a "connection" page, showing publications Jeffrey Jones has written about Risk Factors.
Connection Strength
0.134
-
Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease. J Thorac Cardiovasc Surg. 2013 May; 145(5):1326-33.
Score: 0.052
-
The pathogenesis of aortopathy in Marfan syndrome and related diseases. Curr Cardiol Rep. 2010 Mar; 12(2):99-107.
Score: 0.043
-
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia. JAMA Oncol. 2015 Apr; 1(1):80-7.
Score: 0.015
-
Pathophysiology of thoracic aortic aneurysm (TAA): is it not one uniform aorta? Role of embryologic origin. Prog Cardiovasc Dis. 2013 Jul-Aug; 56(1):68-73.
Score: 0.013
-
Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease. J Clin Oncol. 2009 Dec 10; 27(35):6012-8.
Score: 0.010